{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:11:49Z","timestamp":1783987909551,"version":"3.55.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52886-w","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:14:13Z","timestamp":1778670853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A prospective observational study evaluating drug-related problems and their impact on patient-related outcomes in hospitalized epileptic patients"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6369-1510","authenticated-orcid":false,"given":"Muhammad","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3639-0026","authenticated-orcid":false,"given":"Muhammad Harris","family":"Shoaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quratulain","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Zeb-un-Nisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Irshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"52886_CR1","unstructured":"Jankovic, J., Mazziotta, J. C. & Pomeroy, S. L. Bradley\u2019s Neurology in Clinical Practice E-Book (Elsevier Health Sciences, 2021)."},{"key":"52886_CR2","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","volume":"46","author":"RS Fisher","year":"2005","unstructured":"Fisher, R. S. et al. Epileptic seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46, 470\u2013472 (2005).","journal-title":"Epilepsia"},{"key":"52886_CR3","doi-asserted-by":"crossref","unstructured":"Chauhan, P., Philip, S. E., Chauhan, G. & Mehra, S. (2022). The anatomical basis of seizures.","DOI":"10.36255\/exon-publications-epilepsy-anatomical-basis"},{"key":"52886_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher, R. S. et al. ILAE official report: A practical clinical definition of epilepsy. Epilepsia 55, 475\u2013482 (2014).","journal-title":"Epilepsia"},{"key":"52886_CR5","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/epi.17239","volume":"63","author":"SM Zuberi","year":"2022","unstructured":"Zuberi, S. M. et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia 63, 1349\u20131397 (2022).","journal-title":"Epilepsia"},{"key":"52886_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000503831","volume":"54","author":"E Beghi","year":"2020","unstructured":"Beghi, E. The epidemiology of epilepsy. Neuroepidemiology 54, 185\u2013191 (2020).","journal-title":"Neuroepidemiology"},{"key":"52886_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","volume":"393","author":"RD Thijs","year":"2019","unstructured":"Thijs, R. D., Surges, R., O\u2019Brien, T. J. & Sander, J. W. Epilepsy in adults. The lancet 393, 689\u2013701 (2019).","journal-title":"The lancet"},{"key":"52886_CR8","doi-asserted-by":"crossref","unstructured":"Farrukh, M. J., Makmor-Bakry, M., Hatah, E. & Tan, H. J. Use of complementary and alternative medicine and adherence to antiepileptic drug therapy among epilepsy patients: A systematic review. Patient Prefer. Adherence. 2111-2121 (2018).","DOI":"10.2147\/PPA.S179031"},{"key":"52886_CR9","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/epi.16856","volume":"62","author":"A Guekht","year":"2021","unstructured":"Guekht, A. et al. The road to a World Health Organization global action plan on epilepsy and other neurological disorders. Epilepsia 62, 1057\u20131063 (2021).","journal-title":"Epilepsia"},{"key":"52886_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","volume":"14","author":"JP Betjemann","year":"2015","unstructured":"Betjemann, J. P. & Lowenstein, D. H. Status epilepticus in adults. Lancet Neurol. 14, 615\u2013624 (2015).","journal-title":"Lancet Neurol."},{"key":"52886_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/epi.14484","volume":"59","author":"B Lee","year":"2018","unstructured":"Lee, B. Treatment gap for convulsive status epilepticus in resource-poor countries. Epilepsia 59, 135\u2013139 (2018).","journal-title":"Epilepsia"},{"key":"52886_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1684\/epd.2016.0832","volume":"18","author":"H Hassan","year":"2016","unstructured":"Hassan, H. et al. An audit of the predictors of outcome in status epilepticus from a resource-poor country: A comparison with developed countries. Epileptic Disord. 18, 163\u2013172 (2016).","journal-title":"Epileptic Disord."},{"key":"52886_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","volume":"17","author":"GM Brophy","year":"2012","unstructured":"Brophy, G. M. et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit. Care 17, 3\u201323 (2012).","journal-title":"Neurocrit. Care"},{"key":"52886_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5698\/1535-7511-14.s2.43","volume":"14","author":"DH Lowenstein","year":"2014","unstructured":"Lowenstein, D. H., Walker, M. & Waterhouse, E. Status epilepticus in the setting of acute encephalitis: Status epilepticus in the setting of acute encephalitis. Epilepsy Curr. 14, 43\u201349 (2014).","journal-title":"Epilepsy Curr."},{"key":"52886_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42494-021-00068-8","volume":"4","author":"J Chen","year":"2022","unstructured":"Chen, J., Ye, H., Zhang, J., Li, A. & Ni, Y. Pathogenesis of seizures and epilepsy after stroke. Acta Epileptol. 4, 1\u20136 (2022).","journal-title":"Acta Epileptol."},{"key":"52886_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/psb.1662","volume":"29","author":"C Prager","year":"2018","unstructured":"Prager, C. & Cross, J. H. Diagnosis and management of the epilepsies in children. Prescriber 29, 13\u201319 (2018).","journal-title":"Prescriber"},{"key":"52886_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.636045","volume":"12","author":"K Bauman","year":"2021","unstructured":"Bauman, K. & Devinsky, O. Seizure clusters: Morbidity and mortality. Front. Neurol. 12, 636045 (2021).","journal-title":"Front. Neurol."},{"key":"52886_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.eplepsyres.2017.04.016","volume":"133","author":"B Chen","year":"2017","unstructured":"Chen, B. et al. Prevalence and risk factors of seizure clusters in adult patients with epilepsy. Epilepsy Res. 133, 98\u2013102 (2017).","journal-title":"Epilepsy Res."},{"key":"52886_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11940-016-0401-x","volume":"18","author":"JG Ochoa","year":"2016","unstructured":"Ochoa, J. G. & Kilgo, W. A. The role of benzodiazepines in the treatment of epilepsy. Curr. Treat. Options Neurol. 18, 1\u201311 (2016).","journal-title":"Curr. Treat. Options Neurol."},{"key":"52886_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.yebeh.2009.02.030","volume":"15","author":"D Schmidt","year":"2009","unstructured":"Schmidt, D. Drug treatment of epilepsy: Options and limitations. Epilepsy Behav. 15, 56\u201365 (2009).","journal-title":"Epilepsy Behav."},{"key":"52886_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","volume":"75","author":"Z Chen","year":"2018","unstructured":"Chen, Z., Brodie, M. J., Liew, D. & Kwan, P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: A 30-year longitudinal cohort study. JAMA Neurol. 75, 279\u2013286 (2018).","journal-title":"JAMA Neurol."},{"key":"52886_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.14581\/jer.20011","volume":"10","author":"M Nazir","year":"2020","unstructured":"Nazir, M., Tarray, R. A., Asimi, R. & Syed, W. A. Comparative efficacy of IV phenytoin, IV valproate, and IV levetiracetam in childhood status epilepticus. J. Epilepsy Res. 10, 69 (2020).","journal-title":"J. Epilepsy Res."},{"key":"52886_CR23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1212\/01.CON.0000431379.29065.d3","volume":"19","author":"F Cendes","year":"2013","unstructured":"Cendes, F. Neuroimaging in investigation of patients with epilepsy. CONTINUUM: Lifelong Learn. Neurol. 19, 623\u2013642 (2013).","journal-title":"CONTINUUM: Lifelong Learn. Neurol."},{"key":"52886_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1136\/practneurol-2018-002180","volume":"19","author":"JS Duncan","year":"2019","unstructured":"Duncan, J. S. Brain imaging in epilepsy. Pract. Neurol. 19, 438\u2013443 (2019).","journal-title":"Pract. Neurol."},{"key":"52886_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00701","volume":"11","author":"T Kim","year":"2020","unstructured":"Kim, T. et al. Epileptic seizure detection and experimental treatment: A review. Front. Neurol. 11, 701 (2020).","journal-title":"Front. Neurol."},{"key":"52886_CR26","doi-asserted-by":"crossref","unstructured":"Kanner, A. M. & Hesdorffer, D. C. Neuropsychiatric complications of epilepsy. In Handbook of clinical neurology Vol. 107 461\u2013482 (2012).","DOI":"10.1016\/B978-0-444-52898-8.00037-9"},{"key":"52886_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-22159-5","volume-title":"Neuropsychiatric symptoms of epilepsy","author":"M Mula","year":"2016","unstructured":"Mula, M. Neuropsychiatric symptoms of epilepsy (Springer, 2016)."},{"key":"52886_CR28","doi-asserted-by":"crossref","unstructured":"Sahar, N.-u. Assessment of psychological distress in epilepsy: Perspective from Pakistan. Epilepsy Res. Treat. 2012, 171725 (2012).","DOI":"10.1155\/2012\/171725"},{"key":"52886_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/epi.14458","volume":"60","author":"E Trinka","year":"2019","unstructured":"Trinka, E., Kwan, P., Lee, B. & Dash, A. Epilepsy in Asia: Disease burden, management barriers, and challenges. Epilepsia 60, 7\u201321 (2019).","journal-title":"Epilepsia"},{"key":"52886_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106637","volume":"102","author":"Z Mogal","year":"2020","unstructured":"Mogal, Z. & Aziz, H. Epilepsy treatment gap and stigma reduction in Pakistan: A tested public awareness model. Epilepsy Behav. 102, 106637 (2020).","journal-title":"Epilepsy Behav."},{"key":"52886_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.seizure.2018.02.002","volume":"56","author":"C Espinosa-Jovel","year":"2018","unstructured":"Espinosa-Jovel, C., Toledano, R., Aledo-Serrano, \u00c1., Garc\u00eda-Morales, I. & Gil-Nagel, A. Epidemiological profile of epilepsy in low income populations. Seizure 56, 67\u201372 (2018).","journal-title":"Seizure"},{"key":"52886_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.phrs.2016.03.003","volume":"107","author":"E Beghi","year":"2016","unstructured":"Beghi, E. Addressing the burden of epilepsy: Many unmet needs. Pharmacol. Res. 107, 79\u201384 (2016).","journal-title":"Pharmacol. Res."},{"key":"52886_CR33","doi-asserted-by":"crossref","unstructured":"Al-Worafi, Y. M. Health Economics in Developing Countries. In Handbook of Medical and Health Sciences in Developing Countries: Education, Practice, and Research 1\u201327 (Springer, 2024).","DOI":"10.1007\/978-3-030-74786-2_129-1"},{"key":"52886_CR34","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.2174\/1381612823666170809103202","volume":"23","author":"J Jost","year":"2017","unstructured":"Jost, J., Millogo, A. & Preux, P.-M. Antiepileptic treatments in developing countries. Curr. Pharm. Des. 23, 5740\u20135748 (2017).","journal-title":"Curr. Pharm. Des."},{"key":"52886_CR35","first-page":"3","volume":"12","author":"G Hussain","year":"2017","unstructured":"Hussain, G. et al. Neurological disorder burden in faisalabad, punjab-pakistan: data from the major tertiary carecenters of the city. Pakistan J. Neurol. Sci. (PJNS). 12, 3\u201310 (2017).","journal-title":"Pakistan J. Neurol. Sci. (PJNS)"},{"key":"52886_CR36","first-page":"52","volume":"12","author":"G Hussain","year":"2017","unstructured":"Hussain, G. et al. Epidemiological data of neurological disorders in Pakistan and neighboring countries: a review. Pakistan J. Neurol. Sci. (PJNS). 12, 52\u201370 (2017).","journal-title":"Pakistan J. Neurol. Sci. (PJNS)"},{"key":"52886_CR37","first-page":"5956","volume":"31","author":"S Salekeen","year":"2013","unstructured":"Salekeen, S. et al. Clinical course, complications and predictors of mortality in patients with tuberculous meningitis\u2014an experience of fifty two cases at Civil Hospital Karachi, Pakistan. Headache 31, 5956 (2013).","journal-title":"Headache"},{"key":"52886_CR38","doi-asserted-by":"crossref","unstructured":"Al-Worafi, Y. M. Drug-related problems. In Drug safety in developing countries 105\u2013117 (Elsevier, 2020).","DOI":"10.1016\/B978-0-12-819837-7.00009-1"},{"key":"52886_CR39","doi-asserted-by":"publisher","DOI":"10.1177\/20503121211009728","volume":"9","author":"Y Ayele","year":"2021","unstructured":"Ayele, Y. & Tesfaye, Z. T. Drug-related problems in Ethiopian public healthcare settings: Systematic review and meta-analysis. SAGE Open Med. 9, 20503121211009728 (2021).","journal-title":"SAGE Open Med."},{"key":"52886_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0299968","volume":"19","author":"YL Niriayo","year":"2024","unstructured":"Niriayo, Y. L., Gebregziabher, T., Demoz, G. T., Tesfay, N. & Gidey, K. Drug therapy problems and contributing factors among patients with epilepsy. PLoS One 19, e0299968 (2024).","journal-title":"PLoS One"},{"key":"52886_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295208","volume":"19","author":"M Ali","year":"2024","unstructured":"Ali, M. et al. A prospective observational study of estimating drug related problems and clinical outcomes in subtypes of stroke patients. PLoS One 19, e0295208 (2024).","journal-title":"PLoS One"},{"key":"52886_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-80560-2","volume":"11","author":"N Garin","year":"2021","unstructured":"Garin, N. et al. Drug related problems in clinical practice: A cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions. Sci. Rep. 11, 1\u201311 (2021).","journal-title":"Sci. Rep."},{"key":"52886_CR43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.gaceta.2011.05.016","volume":"25","author":"RS Andreazza","year":"2011","unstructured":"Andreazza, R. S., De Castro, M. S., K\u00f6che, P. S. & Heineck, I. Causes of drug-related problems in the emergency room of a hospital in Southern Brazil. Gac. Sanit. 25, 501\u2013506 (2011).","journal-title":"Gac. Sanit."},{"key":"52886_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227359","volume":"15","author":"BB Nasir","year":"2020","unstructured":"Nasir, B. B. et al. Drug therapy problems and treatment satisfaction among ambulatory patients with epilepsy in a specialized hospital in Ethiopia. PLoS One 15, e0227359 (2020).","journal-title":"PLoS One"},{"key":"52886_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285171","volume":"18","author":"M Ali","year":"2023","unstructured":"Ali, M. et al. Assessment of potential drug-related problems (PDRP) and clinical outcomes in bacterial meningitis patients admitted to tertiary care hospitals. PLoS One 18, e0285171 (2023).","journal-title":"PLoS One"},{"key":"52886_CR46","unstructured":"Association, P. C. N. E. (2020)."},{"key":"52886_CR47","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1093\/cid\/ciz613","volume":"69","author":"J Baloh","year":"2019","unstructured":"Baloh, J. et al. Healthcare workers\u2019 strategies for doffing personal protective equipment. Clin. Infect. Dis. 69, S192\u2013S198 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"52886_CR48","doi-asserted-by":"publisher","first-page":"e12938","DOI":"10.1111\/ina.12938","volume":"32","author":"MF King","year":"2022","unstructured":"King, M. F. et al. Modeling fomite-mediated SARS\u2010CoV\u20102 exposure through personal protective equipment doffing in a hospital environment. Indoor Air. 32, e12938 (2022).","journal-title":"Indoor Air"},{"key":"52886_CR49","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1002\/jcph.1282","volume":"58","author":"MJ Kim","year":"2018","unstructured":"Kim, M. J., Yum, M. S., Yeh, H. R., Ko, T. S. & Lim, H. S. Pharmacokinetic and pharmacodynamic evaluation of intravenous levetiracetam in children with epilepsy. J. Clin. Pharmacol. 58, 1586\u20131596 (2018).","journal-title":"J. Clin. Pharmacol."},{"key":"52886_CR50","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3163\/1536-5050.104.4.007","volume":"104","author":"RI Patel","year":"2016","unstructured":"Patel, R. I. & Beckett, R. D. Evaluation of resources for analyzing drug interactions. J. Med. Libr. Assoc. 104, 290 (2016).","journal-title":"J. Med. Libr. Assoc."},{"key":"52886_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-022-01949-9","volume":"22","author":"BP Kho","year":"2022","unstructured":"Kho, B. P., Wong, S. M. A., Chiu, J. W. T. & Liew, E. Preference and usage pattern of mobile medical apps for drug information purposes among hospital pharmacists in Sarawak, Malaysia. BMC Med. Inform. Decis. Mak. 22, 199 (2022).","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"52886_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000518439","volume":"107","author":"B Roca","year":"2022","unstructured":"Roca, B. & Roca, M. Assessment of drug interactions with online electronic checkers in multi-pathological patients. Pharmacology 107, 111\u2013115 (2022).","journal-title":"Pharmacology"},{"key":"52886_CR53","doi-asserted-by":"crossref","unstructured":"Organization, W. H. The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2023 (including the 23rd WHO Model List of Essential Medicines and the 9th WHO Model List of Essential Medicines for Children)World Health Organization,. (2024).","DOI":"10.1530\/ey.19.13.1"},{"key":"52886_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216122","volume":"14","author":"A Saeed","year":"2019","unstructured":"Saeed, A., Saeed, H., Saleem, Z., Fang, Y. & Babar, Z.-U.-D. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO\/HAI methodology. PLoS One 14, e0216122 (2019).","journal-title":"PLoS One"},{"key":"52886_CR55","doi-asserted-by":"publisher","unstructured":"Ali, M. et al. Rational use of antibiotics in an intensive care unit: A retrospective study of the impact on clinical outcomes and mortality rate. Infect. Drug Resist. 12, 493-499, https:\/\/doi.org\/10.2147\/IDR.S187836 (2019).","DOI":"10.2147\/IDR.S187836"},{"key":"52886_CR56","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00228-019-02796-w","volume":"76","author":"E Puumalainen","year":"2020","unstructured":"Puumalainen, E., Airaksinen, M., Jalava, S. E., Chen, T. F. & Dimitrow, M. Comparison of drug-related problem risk assessment tools for older adults: A systematic review. Eur. J. Clin. Pharmacol. 76, 337\u2013348 (2020).","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"10","key":"52886_CR57","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3390\/antibiotics11101381","volume":"11","author":"U Wolf","year":"2022","unstructured":"Wolf, U. et al. Individual pharmacotherapy management (IPM)\u2014IV: Optimized usage of approved antimicrobials addressing under-recognized adverse drug reactions and drug-drug interactions in polypharmacy. Antibiotics 11(10), 1381 (2022).","journal-title":"Antibiotics"},{"key":"52886_CR58","doi-asserted-by":"publisher","unstructured":"Atif, M. et al. Pharmaceutical policy in Pakistan. Pharmaceutical policy Ctries. developing Healthc. systems. Adis, Cham. 25\u201344 https:\/\/doi.org\/10.1007\/978-3-319-51673-8_3 (2017).","DOI":"10.1007\/978-3-319-51673-8_3"},{"key":"52886_CR59","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/cid\/ciw504","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil, A. C. et al. Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin. Infect. Dis. 63, 575\u2013582 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"52886_CR60","doi-asserted-by":"crossref","unstructured":"Rivera-Lara, L., Ziai, W. & Nyquist, P. Management of infections associated with neurocritical care. In Handbook of Clinical Neurology Vol. 140 365\u2013378 (2017).","DOI":"10.1016\/B978-0-444-63600-3.00020-9"},{"key":"52886_CR61","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1542\/hpeds.2015-0249","volume":"6","author":"MB Lebowitz","year":"2016","unstructured":"Lebowitz, M. B., Olson, K. L., Burns, M., Harper, M. B. & Bourgeois, F. Drug-drug interactions among hospitalized children receiving chronic antiepileptic drug therapy. Hosp. Pediatr. 6, 282\u2013289 (2016).","journal-title":"Hosp. Pediatr."},{"key":"52886_CR62","doi-asserted-by":"publisher","first-page":"674483","DOI":"10.3389\/fneur.2021.674483","volume":"12","author":"A Fattorusso","year":"2021","unstructured":"Fattorusso, A. et al. The pharmacoresistant epilepsy: an overview on existant and new emerging therapies. Front. Neurol. 12, 674483 (2021).","journal-title":"Front. Neurol."},{"key":"52886_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-023-03508-9","volume":"24","author":"OH Urio","year":"2024","unstructured":"Urio, O. H., Kija, E., Weckhuysen, S., Makungu, H. & Naburi, H. Drug resistant epilepsy and associated factors among children with epilepsies in Tanzania: A cross-sectional study. BMC Neurol. 24, 8 (2024).","journal-title":"BMC Neurol."},{"key":"52886_CR64","doi-asserted-by":"crossref","unstructured":"Engel, J. Jr. What can we do for people with drug-resistant epilepsy? The 2016 Wartenberg Lecture. Neurology 87, 2483\u20132489 (2016).","DOI":"10.1212\/WNL.0000000000003407"},{"key":"52886_CR65","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10072-012-1001-5","volume":"34","author":"UK Misra","year":"2013","unstructured":"Misra, U. K., Kalita, J., Chandra, S. & Nair, P. P. Association of antibiotics with status epilepticus. Neurol. Sci. 34, 327\u2013331 (2013).","journal-title":"Neurol. Sci."},{"key":"52886_CR66","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40138-022-00250-3","volume":"10","author":"R John","year":"2022","unstructured":"John, R. et al. Evaluation and treatment of adult status epilepticus in the emergency department. Curr. Emerg. Hosp. Med. Rep. 10, 107\u2013115 (2022).","journal-title":"Curr. Emerg. Hosp. Med. Rep."},{"key":"52886_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208447","volume":"13","author":"GB Gebretekle","year":"2018","unstructured":"Gebretekle, G. B. et al. Opportunities and barriers to implementing antibiotic stewardship in low and middle-income countries: Lessons from a mixed-methods study in a tertiary care hospital in Ethiopia. PLoS One 13, e0208447 (2018).","journal-title":"PLoS One"},{"key":"52886_CR68","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1016\/S1473-3099(16)30386-3","volume":"17","author":"DA Goff","year":"2017","unstructured":"Goff, D. A. et al. A global call from five countries to collaborate in antibiotic stewardship: United we succeed, divided we might fail. Lancet. Infect. Dis. 17, e56\u2013e63 (2017).","journal-title":"Lancet. Infect. Dis."},{"key":"52886_CR69","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1111\/j.1528-1167.2012.03576.x","volume":"53","author":"R Sutter","year":"2012","unstructured":"Sutter, R. et al. Associations between infections and clinical outcome parameters in status epilepticus: A retrospective 5-year cohort study. Epilepsia 53, 1489\u20131497 (2012).","journal-title":"Epilepsia"},{"key":"52886_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258602","volume":"16","author":"A Garc\u00eda-Villafranca","year":"2021","unstructured":"Garc\u00eda-Villafranca, A. et al. De-novo non-convulsive status epilepticus in adult medical inpatients without known epilepsy: Analysis of mortality related factors and literature review. PLoS One 16, e0258602 (2021).","journal-title":"PLoS One"},{"key":"52886_CR71","first-page":"29","volume":"49","author":"O Dayts","year":"2014","unstructured":"Dayts, O. Evidence-based protocol: Diagnosis and treatment of catheter-associated urinary tract infection within adult neurocritical care patient population. Nurs. Clin. 49, 29\u201343 (2014).","journal-title":"Nurs. Clin."},{"key":"52886_CR72","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","volume":"131","author":"A Vezzani","year":"2016","unstructured":"Vezzani, A. et al. Infections, inflammation and epilepsy. Acta Neuropathol. 131, 211\u2013234 (2016).","journal-title":"Acta Neuropathol."},{"issue":"1","key":"52886_CR73","doi-asserted-by":"publisher","first-page":"10755","DOI":"10.1038\/s41598-018-28916-7","volume":"8","author":"PIP Ramos","year":"2018","unstructured":"Ramos, P. I. P. et al. An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets. Sci. Rep. 8 (1), 10755 (2018).","journal-title":"Sci. Rep."},{"issue":"3","key":"52886_CR74","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/microorganisms11030661","volume":"11","author":"MT Alharbi","year":"2023","unstructured":"Alharbi, M. T. et al. Antimicrobial resistance pattern, pathogenicity and molecular properties of hypervirulent Klebsiella pneumonia (hvKp) among hospital-acquired infections in the intensive care unit (ICU). Microorganisms 11(3), 661 (2023).","journal-title":"Microorganisms"},{"key":"52886_CR75","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1590\/0004-282X20150043","volume":"73","author":"TM Assis","year":"2015","unstructured":"Assis, T. M., Bacellar, A., Costa, G. & Nascimento, O. J. Mortality predictors of epilepsy and epileptic seizures among hospitalized elderly. Arq. Neuropsiquiatr. 73, 510\u2013515 (2015).","journal-title":"Arq. Neuropsiquiatr."},{"key":"52886_CR76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1053\/j.ackd.2019.08.001","volume":"27","author":"MC Morales-Alvarez","year":"2020","unstructured":"Morales-Alvarez, M. C. Nephrotoxicity of antimicrobials and antibiotics. Adv. Chronic Kidney Dis. 27, 31\u201337 (2020).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"52886_CR77","doi-asserted-by":"publisher","first-page":"s82","DOI":"10.1590\/1806-9282.66.s1.82","volume":"66","author":"GTM Sales","year":"2020","unstructured":"Sales, G. T. M. & Foresto, R. D. Drug-induced nephrotoxicity. Rev. Assoc. Med. Bras. 66, s82\u2013s90 (2020).","journal-title":"Rev. Assoc. Med. Bras."},{"key":"52886_CR78","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0140-6736(13)60647-9","volume":"382","author":"NH Lameire","year":"2013","unstructured":"Lameire, N. H. et al. Acute kidney injury: An increasing global concern. The Lancet 382, 170\u2013179 (2013).","journal-title":"The Lancet"},{"key":"52886_CR79","first-page":"31","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft, D. W. & Gault, H. Prediction of creatinine clearance from serum creatinine. Nephron 16, 31\u201341 (1976).","journal-title":"Nephron"},{"key":"52886_CR80","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/epi.17155","volume":"63","author":"V Pironi","year":"2022","unstructured":"Pironi, V. et al. Survey on the worldwide availability and affordability of antiseizure medications: Report of the ILAE task force on access to treatment. Epilepsia 63, 335\u2013351 (2022).","journal-title":"Epilepsia"},{"key":"52886_CR81","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/epi.17877","volume":"65","author":"E Perucca","year":"2024","unstructured":"Perucca, E. et al. Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper. Epilepsia 65, 533\u2013541 (2024).","journal-title":"Epilepsia"},{"key":"52886_CR82","unstructured":"Levy, R. H. Antiepileptic drugs (Lippincott Williams & Wilkins, 2002)."},{"key":"52886_CR83","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.3928\/00904481-20150203-10","volume":"44","author":"R Sankaraneni","year":"2015","unstructured":"Sankaraneni, R. & Lachhwani, D. Antiepileptic drugs\u2014a review. Pediatr. Ann. 44, e36\u2013e42 (2015).","journal-title":"Pediatr. Ann."},{"key":"52886_CR84","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1212\/CON.0000000000000225","volume":"21","author":"SE Hocker","year":"2015","unstructured":"Hocker, S. E. Status epilepticus. CONTINUUM: Lifelong Learn. Neurol. 21, 1362\u20131383 (2015).","journal-title":"CONTINUUM: Lifelong Learn. Neurol."},{"key":"52886_CR85","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1007\/s00415-018-8943-3","volume":"265","author":"HM Braakman","year":"2018","unstructured":"Braakman, H. M. & van Ingen, J. Can epilepsy be treated by antibiotics?. J. Neurol. 265, 1934\u20131936 (2018).","journal-title":"J. Neurol."},{"key":"52886_CR86","doi-asserted-by":"publisher","unstructured":"Schmidt, D. & Schachter, S. C. Drug treatment of epilepsy in adults. Bmj 348, g254 https:\/\/doi.org\/10.1136\/bmj.g254 (2014).","DOI":"10.1136\/bmj.g254"},{"key":"52886_CR87","doi-asserted-by":"publisher","unstructured":"Abdinia, B., Rezaee, M. A. & Oskouie, S. A. Etiology and antimicrobial resistance patterns of acute bacterial meningitis in children: A 10-year referral hospital-based study in northwest Iran. Iran. Red Crescent Med. J. 16(7), e17616 https:\/\/doi.org\/10.5812\/ircmj.17616 (2014).","DOI":"10.5812\/ircmj.17616"},{"issue":"2","key":"52886_CR88","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/pediatric14020038","volume":"14","author":"HA Nawaz","year":"2022","unstructured":"Nawaz, H. A. et al. A Prospective Study of Medication Surveillance of a Pediatric Tertiary Care Hospital in Lahore, Pakistan. Pediatr. Rep. 14 (2), 312\u2013319 (2022).","journal-title":"Pediatr. Rep."},{"issue":"7","key":"52886_CR89","first-page":"702","volume":"26","author":"ML Christensen","year":"2021","unstructured":"Christensen, M. L. et al. Concomitant ceftriaxone and intravenous calcium therapy in infants. J. Pediatr. Pharmacol. Ther. 26 (7), 702\u2013707 (2021).","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"52886_CR90","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1080\/02699052.2020.1831606","volume":"34","author":"TH Chua","year":"2020","unstructured":"Chua, T. H., Xu, Z. & King, N. K. K. Neurological manifestations in COVID-19: A systematic review and meta-analysis. Brain Inj. 34, 1549\u20131568 (2020).","journal-title":"Brain Inj."},{"key":"52886_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108379","volume":"125","author":"A Sanchez-Larsen","year":"2021","unstructured":"Sanchez-Larsen, A. et al. COVID-19 prevalence and mortality in people with epilepsy: A nation-wide multicenter study. Epilepsy Behav. 125, 108379 (2021).","journal-title":"Epilepsy Behav."},{"key":"52886_CR92","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.seizure.2021.11.017","volume":"94","author":"H Daniels","year":"2022","unstructured":"Daniels, H. et al. Epilepsy mortality in Wales during COVID-19. Seizure 94, 39\u201342 (2022).","journal-title":"Seizure"},{"key":"52886_CR93","doi-asserted-by":"publisher","unstructured":"Ali, A. Global health: epilepsy. in Seminars in neurology. 2018. Thieme Medical Publishers. Semin Neurol 2018; 38 (02), 191\u2013199 https:\/\/doi.org\/10.1055\/s-0038-1646947.","DOI":"10.1055\/s-0038-1646947"},{"key":"52886_CR94","doi-asserted-by":"publisher","first-page":"693","DOI":"10.7196\/SAMJnew.8039","volume":"105","author":"E Lee-Pan","year":"2015","unstructured":"Lee-Pan, E. & Tucker, L. An approach to epilepsy. South. Afr. Med. J. 105, 693\u2013693 (2015).","journal-title":"South. Afr. Med. J."},{"key":"52886_CR95","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1742-7843.2007.00206.x","volume":"102","author":"KK Viktil","year":"2008","unstructured":"Viktil, K. K. & Blix, H. S. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin. Pharmacol. Toxicol. 102, 275\u2013280 (2008).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"52886_CR96","first-page":"12","volume":"5","author":"MJ Farrukh","year":"2014","unstructured":"Farrukh, M. J., Hisham, S. A. & Bin Zainal, Z. A. Pharmaceutical care issues in patients with atrial fibrillation receiving thromboprophylaxis. Am. J. Pharmacol. Sci. 5, 12\u201316 (2014).","journal-title":"Am. J. Pharmacol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52886-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:02:47Z","timestamp":1783987367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52886-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52886"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52886-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21904"}}